129 related articles for article (PubMed ID: 38622910)
1. Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
Alqahtani SA; Yilmaz Y; El-Kassas M; Alswat K; Sanai F; AlZahrani M; Abaalkhail F; AlShaikh M; Al-Hamoudi WK; Nader F; Stepanova M; Younossi ZM;
J Viral Hepat; 2024 Jun; 31(6):300-308. PubMed ID: 38622910
[TBL] [Abstract][Full Text] [Related]
2. Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
Younossi ZM; Yu ML; Yilmaz Y; Alswat KA; Buti M; Fernandez MIC; Papatheodoridis G; Hamid SS; El-Kassas M; Chan WK; Duseja AK; Gordon SC; Eguchi Y; Isakov VA; Roberts SK; Fan JG; Singal AK; Romero-Gómez M; Ahmed A; Ong J; Lam BP; Younossi I; Nader F; Racila A; Stepanova M; Alqahtani S
J Viral Hepat; 2023 Apr; 30(4):335-344. PubMed ID: 36601668
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009
[TBL] [Abstract][Full Text] [Related]
4. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
[TBL] [Abstract][Full Text] [Related]
5. Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study.
Yilmaz Y; Toraman AE; Alp C; Doğan Z; Keklikkiran C; Stepanova M; Younossi Z
Aliment Pharmacol Ther; 2023 Jan; 57(2):215-223. PubMed ID: 36369643
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Yamamura S; Nakano D; Hashida R; Tsutsumi T; Kawaguchi T; Okada M; Isoda H; Takahashi H; Matsuse H; Eguchi Y; Sumida Y; Nakajima A; Gerber L; Younossi ZM; Torimura T
J Gastroenterol Hepatol; 2021 Mar; 36(3):629-636. PubMed ID: 32627871
[TBL] [Abstract][Full Text] [Related]
8. Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Younossi ZM; Stepanova M; Anstee QM; Lawitz EJ; Wai-Sun Wong V; Romero-Gomez M; Kersey K; Li G; Subramanian GM; Myers RP; Djedjos CS; Okanoue T; Trauner M; Goodman Z; Harrison SA
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2552-2560.e10. PubMed ID: 30779990
[TBL] [Abstract][Full Text] [Related]
9. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
10. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
Younossi ZM; Stepanova M; Lawitz EJ; Reddy KR; Wai-Sun Wong V; Mangia A; Muir AJ; Jacobson I; Djedjos CS; Gaggar A; Myers RP; Younossi I; Nader F; Racila A
Am J Gastroenterol; 2019 Oct; 114(10):1636-1641. PubMed ID: 31464743
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.
Buti M; Stepanova M; Palom A; Riveiro-Barciela M; Nader F; Roade L; Esteban R; Younossi Z
JHEP Rep; 2021 Jun; 3(3):100280. PubMed ID: 34041466
[TBL] [Abstract][Full Text] [Related]
12. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
13. Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
Younossi ZM; Yu ML; El-Kassas M; Esmat G; Castellanos Fernández MI; Buti M; Papatheodoridis G; Yilmaz Y; Isakov V; Duseja A; Méndez-Sánchez N; Hamid S; Gordon SC; Romero-Gómez M; Chan WK; Ong JP; Younossi I; Lam B; Ziayee M; Nader F; Racila A; Henry L; Stepanova M;
J Viral Hepat; 2022 Nov; 29(11):1015-1025. PubMed ID: 36036096
[TBL] [Abstract][Full Text] [Related]
14. Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia.
Sanai FM; Alghamdi H; Alswat KA; Babatin MA; Ismail MH; Alhamoudi WK; Alalwan AM; Dahlan Y; Alghamdi AS; Alfaleh FZ; Aljumah AA; Altraif IH; Albeladi K; Batwa F; Alshumrani W; Belhadi D; Genestier V; Abdo AA
Saudi J Gastroenterol; 2019; 25(3):194-200. PubMed ID: 30720002
[TBL] [Abstract][Full Text] [Related]
15. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
O'Hara J; Finnegan A; Dhillon H; Ruiz-Casas L; Pedra G; Franks B; Morgan G; Hebditch V; Jönsson B; Mabhala M; Reic T; Van Thiel I; Ratziu V; Romero-Gomez M; Bugianesi E; Schattenberg JM; Anstee QM
JHEP Rep; 2020 Oct; 2(5):100142. PubMed ID: 32775976
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience.
Castellanos-Fernández MI; Borges-González SA; Stepanova M; Infante-Velázquez ME; Ruenes-Domech C; González-Suero SM; Dorta-Guridi Z; Arus-Soler ER; Racila A; Younossi ZM
Ann Hepatol; 2021; 22():100277. PubMed ID: 33130334
[TBL] [Abstract][Full Text] [Related]
17. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study.
Yao R; Lu S; Xue R; Wang J; Qiu Y; Chen Y; Liu J; Zhu L; Zhan J; Jiang S; Yin S; Tong X; Ding W; Li J; Zhu C; Huang R; Wu C
Ann Hepatol; 2024; 29(1):101155. PubMed ID: 37742745
[TBL] [Abstract][Full Text] [Related]
18. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Cirrhosis Collaborators
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
[TBL] [Abstract][Full Text] [Related]
19. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.
Huang Y; Gan Q; Lai R; Wang W; Guo S; Sheng Z; Chen L; Guo Q; Cai W; Wang H; Zhao G; Cao Z; Xie Q
Front Cell Infect Microbiol; 2021; 11():733348. PubMed ID: 35111690
[TBL] [Abstract][Full Text] [Related]
20. Itemization difference of patient-reported outcome in patients with chronic liver disease.
Lin MC; Dai CY; Huang CF; Yeh ML; Liu YC; Hsu PY; Wei YJ; Lee PL; Huang CI; Liang PC; Hsieh MY; Hsieh MH; Jang TY; Lin ZY; Huang JF; Yu ML; Chuang WL
PLoS One; 2022; 17(2):e0264348. PubMed ID: 35192675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
